share

2-(3,4-Dichlorophenyl)-n-Methyl-n-[(1S)-1-Phenyl-2-(1-Pyrrolidinyl)Ethyl]Acetamide Hydrochloride CAS NO 115199-84-3


Unit Price:

CAS No.:115199-84-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

2-(3,4-Dichlorophenyl)-n-Methyl-n-[(1S)-1-Phenyl-2-(1-Pyrrolidinyl)Ethyl]Acetamide Hydrochloride is a high-purity chiral organic compound of significant interest in advanced pharmaceutical research and development. Its complex molecular architecture, featuring a stereogenic center and multiple functional groups, makes it a valuable pharmacological intermediate for the synthesis of novel active pharmaceutical ingredients (APIs). This compound is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of central nervous system (CNS) and other therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key chiral building block in the synthesis of novel drug candidates, particularly those targeting neurological pathways.
  • Chemical Reference Standard: Used in analytical laboratories for method development, validation, and quality control of related pharmaceutical substances.
  • Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
  • Process Chemistry Development: Employed in the scale-up and optimization of synthetic routes for complex, stereospecific molecules.
  • Academic Research: Utilized in university and institutional labs for studies in organic synthesis, asymmetric catalysis, and pharmacology.

Basic Information

Item Detail
Product Name 2-(3,4-Dichlorophenyl)-n-Methyl-n-[(1S)-1-Phenyl-2-(1-Pyrrolidinyl)Ethyl]Acetamide Hydrochloride
CAS No. 115199-84-3
Molecular Formula C21H23Cl2N2O • HCl
Molecular Weight 419.79 g/mol (Free base: 383.33 g/mol)
Synonyms N-Methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]-2-(3,4-dichlorophenyl)acetamide hydrochloride; (S)-N-Methyl-N-(1-phenyl-2-(pyrrolidin-1-yl)ethyl)-2-(3,4-dichlorophenyl)acetamide HCl; Levomilnacipran related compound; F2695; 1-Phenyl-2-(1-pyrrolidinyl)-1-(2-(3,4-dichlorophenyl)acetamido)ethane hydrochloride (S-isomer); Milnacipran impurity; Chiral acetamide derivative.
EINECS Contact for details

Quality Control

Our 2-(3,4-Dichlorophenyl)-n-Methyl-n-[(1S)-1-Phenyl-2-(1-Pyrrolidinyl)Ethyl]Acetamide Hydrochloride is manufactured under strict quality systems to ensure batch-to-batch consistency and high purity. We adhere to ICH guidelines for stability and impurity profiling. Every batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, chiral purity, and related substances, available upon request. Our quality commitment supports compliance in cGMP environments for pharmaceutical research.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥98.0%
Chiral Purity (HPLC) ≥99.0% (S-isomer)
Water Content (KF) ≤1.0%
Residue on Ignition ≤0.1%
Related Substances (HPLC) Total impurities ≤2.0%; Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.